Search Results - "Lulu, Talal Ben"
-
1
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
Published in Molecular oncology (01-12-2023)“…Blocking the mitogen‐activated protein kinase (MAPK) pathway with the MEK1/2 inhibitor trametinib has produced promising results in patients with head and neck…”
Get full text
Journal Article -
2
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…The survival rate for patients with head and neck cancer (HNC) diagnosed with cervical lymph node (cLN) or distant metastasis is low. Genomic alterations in…”
Get full text
Journal Article -
3
A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation
Published in Molecular cancer (14-03-2024)“…Phosphoinositide 3-kinases (PI3Ks) are critical regulators of diverse cellular functions and have emerged as promising targets in cancer therapy. Despite…”
Get full text
Journal Article -
4
Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer
Published in Journal of experimental & clinical cancer research (20-11-2024)“…Abstract Background Basket clinical trials targeting the KRAS G12C -mutation in solid tumors have shown initial promise, including in orphan KRAS G12C head and…”
Get full text
Journal Article